Skip to content

Evaluation of the efficacy and mechanism of transcranial alternating current stimulation in drug addiction intervention

Evaluation of the efficacy and mechanism of transcranial alternating current stimulation in drug addiction intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089773
Enrollment
Unknown
Registered
2024-09-14
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug addiction

Interventions

Group1:After watching the five-minute drug trail video, in-phase transcranial alternating current stimulation at 12 Hz to the frontal and parietal lobes of the right frontoparietal brain network
Group1:After watching the five-minute drug trail video, anti-phase transcranial alternating current stimulation at 12 Hz to the frontal and parietal lobes of the right frontoparietal brain network
Group3:After viewing a five-minute video of scenic cues, 12-Hz in-phase transcranial alternating current stimulation was administered to the frontal and parietal lobes of the right frontoparietal brai
Group4:After viewing a five-minute drug cue video, sham transcranial alternating current stimulation was administered targeting the frontal and parietal lobes of the right frontoparietal brain network

Sponsors

Xidian University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Right-handed, recruited individuals aged 18-60 years with heroin use disorder, male and female. Voluntarily signed informed consent

Exclusion criteria

Exclusion criteria: Patients with a history of head trauma, mental retardation, mental disorders (such as epilepsy, etc.) or chronic pain diseases, and patients who cannot cooperate with examination and treatment; 2. Patients with serious primary diseases such as cancer, heart, liver, lung, kidney, hematopoietic system, etc.; 3. Pregnant or lactating women, allergies and allergies to a variety of drugs; 4. Those who are judged by the radiologist to have organic mass, bright signal or other structural abnormalities in the brain; 5. Those who may have poor compliance and those who are difficult to follow-up; 6. Claustrophobia.

Design outcomes

Primary

MeasureTime frame
electroencephalogram (EEG);electrocardiosignal;psychological scale;

Countries

China

Contacts

Public ContactKai Yuan

Xidian University

kyuan@xidian.edu.cn+86 180 6689 8052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026